Sleep in patients having neuropathic pai

Phase 1

• Conditions: europathic pain; MedDRA version: 21.0Level: LLTClassification code 10054095Term: Neuropathic painSystem Organ Class: 100000004852; MedDRA version: 21.1Level: LLTClassification code 10067547Term: Diabetic peripheral neuropathic painSystem Organ Class: 100000004852; MedDRA version: 20.0Level: LLTClassification code 10077974Term: Peripheral neuropathic painSystem Organ Class: 100000004852; Therapeutic area: Diseases [C] - Nervous System Diseases [C10]

• Registration Number: EUCTR2020-001957-31-FI
• Lead Sponsor: Eija Kalso

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-06-22
• Last Update Posted: 12 July 2021

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Age: 18-75 yrs, neuropathic pain for >3 months, numerical rating scale
intensity for pain 5 or more on a 10 point scale, sleep disturbance >14 in 50% of the patients
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 36
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 4

Exclusion Criteria

Major psychiatric condition, inability to fill in the questionnaires in
Finnish, drugs that affect sleep

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified